Biotech IV Monitor

IONS — Ionis Pharmaceuticals Inc.

$9.3B market cap · 10 upcoming readouts tracked

Clinical trial readout dates for Ionis Pharmaceuticals Inc., compiled from ClinicalTrials.gov, alongside the SEC filings where results are announced. The next expected readout is December 2026.

Next readoutDecember 2026in ~1 month
Upcoming readouts106 Phase 3
Market cap$9.3B
Cash & investments$1.93B~18 quarters at last loss rate
Recent 8-K filings3latest 2026-11-09

Recently completed

The registry reports these trials have finished collecting primary data. Results often follow within months, and the company may already have reported.

Phase 3 ION363
Amyotrophic Lateral Sclerosis · NCT04768972
June 2026
Primary data collected

Upcoming readouts

Phase 3 Donidalorsen
Hereditary Angioedema · NCT05392114
December 2026
Ongoing
Phase 3 Olezarsen
Severe Hypertriglyceridemia · NCT05681351
March 2027
Ongoing
Phase 1/2 ION717
Prion Disease · NCT06153966
April 2027
Ongoing
Phase 3 Olezarsen
Familial Chylomicronemia Syndrome · NCT05185843
June 2027
Ongoing
Phase 3 obudanersen
Angelman Syndrome · NCT06914609
August 2027
Ongoing
Phase 2 ION775
Hypertriglyceridemia; Severe Hypertriglyceridemia · NCT07604974
September 2027
Recruiting
Phase 1/2 ION440
Methyl CpG Binding Protein 2 (MECP2) Duplication Syndrome · NCT06430385
September 2027
Recruiting
Phase 3 Olezarsen
Familial Chylomicronemia Syndrome · NCT05130450
February 2028
Ongoing
Phase 3 obudanersen
Angelman Syndrome · NCT07782827
May 2028
Recruiting
Phase 1/2 ION582
Angelman Syndrome · NCT05127226
March 2029
Ongoing

Cash position

Ionis Pharmaceuticals Inc. reported $1.93B in cash, cash equivalents and marketable securities at Sep 30, 2026 (10-Q filed 2026-11-09). Its net loss for that quarter was $110M; at that rate the cash would last about 18 quarters. This is a rough guide: net loss includes non-cash items such as stock compensation, and does not count money the company may raise, so its own runway guidance can differ.

Recent SEC filings

8-K Results of Operations — earnings, may carry pipeline updates2026-11-09
8-K Other Events — often topline trial data2026-10-23
8-K Other Events — often topline trial data2026-10-21

Companies working on similar indications

Discussion

No messages yet. If you follow IONS, you can start the conversation.
Track IONS in real time
See live implied volatility for IONS and 106 other biotechs, and get alerted when a readout lands.
🔔 Alert me on IONS
Contact — questions or corrections about IONS: dukeupt@gmail.com